Heterozygous Familial Hypercholesterolemia (HeFH)
Symptoms, Doctors, Treatments, Advances & More

Heterozygous Familial Hypercholesterolemia (HeFH) Overview

Save information for later
Sign Up

Learn About Heterozygous Familial Hypercholesterolemia (HeFH)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Heterozygous Familial Hypercholesterolemia (HeFH) Local Doctors?
Elite in Heterozygous Familial Hypercholesterolemia (HeFH)
Elite in Heterozygous Familial Hypercholesterolemia (HeFH)
Referral may be required

Vascular And Endovascular Surgery At The Mount Sinai Hospital

1190 5th Ave Fl 1, 
New York, NY 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Robert Rosenson is a Cardiologist practicing medicine in New York, New York. Dr. Rosenson is rated as an Elite provider by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Homozygous Familial Hypercholesterolemia (HoFH), High Cholesterol, Defective Apolipoprotein B-100, Familial Hypertriglyceridemia, and Percutaneous Coronary Intervention (PCI). Dr. Rosenson is currently accepting new patients.

Elite in Heterozygous Familial Hypercholesterolemia (HeFH)
Elite in Heterozygous Familial Hypercholesterolemia (HeFH)
Referral may be required

Baylor Medicine Atherosclerosis

6655 Travis St, 
Houston, TX 
Experience:
44+ years
Languages Spoken:
English, Spanish
Accepting New Patients

Christie Ballantyne is a Cardiologist practicing medicine in Houston, Texas. He has been practicing medicine for over 44 years. Dr. Ballantyne is rated as an Elite provider by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Familial Hypertriglyceridemia, High Cholesterol, Atherosclerosis, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery. Dr. Ballantyne is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Heterozygous Familial Hypercholesterolemia (HeFH)
Internal Medicine
Distinguished in Heterozygous Familial Hypercholesterolemia (HeFH)
Internal Medicine

IU Health Morgan Physicians LLC

820 N Samuel Moore Pkwy Ste B, 
Mooresville, IN 
Languages Spoken:
English
Accepting New Patients

Charles Christian is a primary care provider, practicing in Internal Medicine in Mooresville, Indiana. Dr. Christian is rated as a Distinguished provider by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Heterozygous Familial Hypercholesterolemia (HeFH), Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia (HoFH), and Hyperlipoproteinemia Type 4. Dr. Christian is currently accepting new patients.

What are the latest Heterozygous Familial Hypercholesterolemia (HeFH) Clinical Trials?
Opportunity to Reach Individuals With Genetic Dyslipidemia During Infancy and the Newborn Period to Find Familial Hypercholesterolemia

Summary: The goal of this clinical trial is to identify different types of Familial Hypercholesterolemia (FH) in infants and newborns. Participants will: * undergo a cheek swab for genetic testing (parents only) * have 5 blood samples collected Participants can expect to be in the trial for 2 years.

Match to trials
Find the right clinical trials for you in under a minute
Get started
An Operationally Seamless Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Enlicitide Decanoate in Pediatric Participants With Heterozygous Familial Hypercholesterolemia

Summary: This study is designed to learn if enlicitide decanoate is safe and effective to treat children and adolescents with heterozygous familial hypercholesterolemia (HeFH) and high amounts of low-density lipoprotein cholesterol (LDL-C) in the blood. The goals of this study are to learn about the safety of enlicitide and if children tolerate it, what happens to enlicitide in a child's body over time, an...